Striatal dopamine transporter availability with [123I]β-CIT SPECT is unrelated to gender or menstrual cycle

Psychopharmacology

Volumn 183, Issue 2, 2005, Pages 181-189

  Best, Susan E ^a   Sarrel, Philip M ^a   Malison, Robert T ^a   Laruelle, Marc ^a,b   Zoghbi, Sami S ^a   Baldwin, Ronald M ^a,b   Seibyl, John P ^a   Innis, Robert B ^a,b   Van Dyck, Christopher H ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

123I CIT; Dopamine transporter; Gender; Menstrual cycle; Serotonin transporter; SPECT; Women

Indexed keywords

3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; BRAIN PROTEIN; DOPAMINE TRANSPORTER; HORMONE; IODINE 123; PROGESTERONE; RADIOLIGAND; SEROTONIN TRANSPORTER;

ADULT; AGE; AGED; ARTICLE; BRAIN LEVEL; BRAIN STEM; CONTROLLED STUDY; CORPUS STRIATUM; DIENCEPHALON; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLICULAR PHASE; HUMAN; ISOTOPE LABELING; LUTEAL PHASE; MALE; MENSTRUAL CYCLE; NORMAL HUMAN; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; QUANTITATIVE ANALYSIS; SEX DIFFERENCE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; COCAINE; CORPUS STRIATUM; DEMOGRAPHY; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENDER IDENTITY; HUMANS; IODINE RADIOISOTOPES; MALE; MENSTRUAL CYCLE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 27744475059     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-005-0158-5     Document Type: Article

References (54)

1. 3H]GBR-12935 binding to cytochrome P450 in the human brain. J Neurochem 62:342-348
2. Andersen SL, Rutstein M, Benzo JM, Hostetter JC, Teicher MH (1997) Sex differences in dopamine receptor overproduction and elimination. Neuroreport 8:1495-1498
3. 125I]RTI-55: a potent ligand for dopamine transporters. Eur J Pharmacol 194:133-134
4. Bossé R, Rivest R, Di Paolo T (1997) Ovariectomy and estradiol treatment affect the dopamine transporter and its gene expression in the rat brain. Brain Res Mol Brain Res 46:343-346
5. Brady KT, Grice DE, Dustan Cl, Randall C (1993) Gender differences in substance use disorders. Am J Psychiatry 150:1707-1711
6. 123I]3β-(4- iodophenyl)tropan-2β-carboxylic acid methyl ester (RTI-55), a unique cocaine receptor ligand for imaging the dopamine and serotonin transporters in vivo. Med Chem Res 1:289-294
7. 3H]paroxetine. Neuroscience 27:473-496
8. Di Paolo T (1994) Modulation of brain dopamine transmission by sex steroids. Rev Neurosci 5:27-42
9. Farde L, Hall H, Pauli S, Halldin C (1995) Variability in D2-dopamine receptor density and affinity: a PET study with [11C] raclopride in man. Synapse 20:200-208
10. Folstein MF, Fostein SE, McHugh PR (1975) "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
11. Gardiner SA, Morrison MF, Mozley PD, Mozley LH, Brensinger C, Bilker W, Newberg A, Battistini M (2004) Pilot study on the effect of estrogen replacement therapy on brain dopamine transporter availability in healthy, postmenopausal women. Am J Geriatr Psychiatry 12:621-630
12. Gunning-Dixon FM, Head D, McQuain J, Acker JD, Raz N (1998) Differential aging of the human striatum: a prospective MR imaging study. AJNR Am J Neuroradiol 19:1501-1507
13. Heinz A, Ragan P, Jones DW, Hommer D, Williams W, Knable MB, Gorey JG, Doty L, Geyer C, Lee KS, Coppola R, Weinberger DR, Linnoila M (1998) Reduced central serotonin transporters in alcoholism. Am J Psychiatry 155:1544-1549
14. Innis RB, Seibyl JP, Scanley BE, Laruelle M, Abi-Dargham A, Wallace E, Baldwin RM, Zea-Ponce Y, Zoghbi S, Wang S, Gao Y, Neumeyer JL, Charney DS, Hoffer PB, Marek KL (1993) Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease. Proc Natl Acad Sci U S A 90:11965-11969
15. Jacobsen LK, Staley JK, Malison RT, Zoghbi SS, Seibyl JP, Kosten TR, Innis RB (2000) Elevated central serotonin transporter binding availability in acutely abstinent cocaine-dependent patients. Am J Psychiatry 157:1134-1140
16. Jernigan TL, Archibald SL, Berhow MT, Sowell ER, Foster DS, Hesselink JR (1991) Cerebral structure on MRI, Part I: localization of age-related changes. Biol Psychiatry 29:55-67
17. Kaasinen V, Nagren K, Hietala J, Farde L, Rinne JO (2001) Sex differences in extrastriatal dopamine d(2)-like receptors in the human brain. Am J Psychiatry 158:308-311
18. Kuikka JT, Tiihonen J, Karhu J, Bergström KA, Räsänen P (1997) Fractal analysis of striatal dopamine re-uptake sites. Eur J Nucl Med 24:1085-1090
19. Kuopio AM, Marttila RJ, Helenius H, Rinne UK (1999) Changing epidemiology of Parkinson's disease in southwestern Finland. Neurology 52:302-308
20. 3H]paroxetine binding, a marker of serotonin uptake sites. Biol Psychiatry 24:299-309
21. 123I]β-CIT: pharmacological characterization of brain uptake in nonhuman primates. Synapse 13:295-309
22. 123I]β-CIT binding to dopamine transporters in healthy human subjects. J Cereb Blood Flow Metab 14:982-994
23. 123I]β-CIT SPECT. Biol Psychiatry 47:371-379
24. 123I]FP-CIT SPET in healthy volunteers. Eur J Nucl Med 27:867-869
25. 123I]β-CIT SPECT imaging demonstrates increased striatal dopamine transporter binding in Tourette's syndrome. Am J Psychiatry 152:1359-1361
26. 123I]β-CIT SPECT. Am J Psychiatry 155:832-834
27. 123I]-2β-carbomethoxy-3β-(4- iodophenyl)tropane and single photon emission computed tomography. Biol Psychiatry 44:1090-1098
28. Metcalf MG, Mackenzie JA (1980) Incidence of ovulation in young women. J Biosoc Sci:345-352
29. Morissette M, Di Paolo T (1993) Sex and estrous cycle variations of rat striatal dopamine uptake sites. Neuroendocrinology 58:16-22
30. Mozley LH, Gur RC, Mozley PD, Gur RE (2001) Striatal dopamine transporters and cognitive functioning in healthy men and women. Am J Psychiatry 158:1492-1499
31. Murphy GM Jr (1985) The human corpus striatum and dentate nucleus: volumetric analysis for hemispheric asymmetries, sex differences, and aging changes. Exp Neurol 89:134-145
32. 123I]-2-β-Carbomethoxy-3-β-(4-iodophenyl)-tropane (β-CIT): high affinity SPECT radiotracer of monoamine reuptake sites in brain. J Med Chem 34:3144-3146
33. 2 dopamine receptor density at different phases of the menstrual cycle. Psychiatry Res 83:1-6
34. Pohjalainen T, Rinne JO, Någren K, Syvälahti E, Hietala J (1998) Sex differences in the striatal dopamine D2 receptor binding characteristics in vivo. Am J Psychiatry 155:768-773
35. 3H-imipramine binding and steroid hormones serum concentrations during the menstrual cycle. Psychopharmacology (Berl) 88:86-89
36. Rivest R, Falardeau P, Di Paolo T (1995) Brain dopamine transporter: gender differences and effect of chronic haloperidol. Brain Res 692:269-272
37. Rojansky N, Halbreich U, Zander K, Barkai A, Goldstein S (1991) Imipramine receptor binding and serotonin uptake in platelets of women with premenstrual changes. Gynecol Obstet Invest 31:146-152
38. Seeman MV (1982) Gender differences in schizophrenia. Can J Psychiatry 27:107-112
39. Seeman MV (1996) The role of estrogen in schizophrenia. J Psychiatry Neurosci 21:123-127
40. Seibyl JP, Wallace E, Smith EO, Stabin M, Baldwin RM, Zea-Ponce Y, Gao Y, Zhang YW, Neumeyer JL, Zubal IG, Charney DS, Hoffer PB, Innis RB (1994) Whole-body biodistribution, radiation absorbed dose, and brain SPECT imaging with iodine-123-β-CIT in healthy human subjects. J Nucl Med 35:764-770
41. 123I]β- CIT striatal uptake correlates with symptom severity in Parkinson's disease. Ann Neurol 38:589-598
42. Seibyl JP, Laruelle M, van Dyck CH, Wallace E, Baldwin RM, Zoghbi SS, Zea-Ponce Y, Neumeyer J, Charney DS, Hoffer PB, Innis RB (1996) Reproducibility of iodine-123-β-CIT SPECT brain measurement of dopamine transporters. J Nucl Med 37:222-228
43. Sofuoglu M, Dudish-Poulsen S, Nelson D, Pentel PR, Hatsukami DK (1999) Sex and menstrual cycle differences in the subjective effects from smoked cocaine in humans. Exp Clin Psychopharmacol 7:274-283
44. Sorenson JA, Phelps ME (1987) Physics in nuclear medicine. Saunders, Philadelphia
45. 3H]GBR 12935 as markers of dopamine innervation density in brain. Synapse 25:163-175
46. 125I]RTI-55: in vitro binding and autoradiographic characterization. J Neurochem 62:549-555
47. 123I]β-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and non-smokers. Synapse 41:275-284
48. Steege JG, Stout AL, Knight DL, Nemeroff CB (1992) Reduced platelet tritium-labeled imipramine binding sites in women with premenstrual syndrome. Am J Obstet Gynecol 167:168-172
49. Tiihonen J, Kuikka J, Bergström K, Hakola P, Karhu J, Ryynänen O-P, Föhr J (1995) Altered striatal dopamine re-uptake site densities in habitually violent and non-violent alcoholics. Nat Med 1:654-657
50. 123I]β-CIT SPECT. J Nucl Med 36:1175-1181
51. 123I]β-CIT SPECT. Neurobiol Aging 21:497-501
52. van Dyck CH, Quinlan DM, Cretella LM, Staley JK, Malison RT, Baldwin RM, Seibyl JP, Innis RB (2002a) Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder. Am J Psychiatry 159:309-312
53. van Dyck CH, Seibyl JP, Malison RT, Laruelle M, Zoghbi SS, Baldwin RM, Innis RB (2002b) Age-related decline in dopamine transporters: analysis of striatal subregions, nonlinear effects, and hemispheric asymmetries. Am J Geriatr Psychiatry 10:36-43
54. Wong DF, Broussolle EP, Wand G, Villemagne V, Dannals RF, Links JM, Zacur HA, Harris J, Naidu S, Braestrup C, Wagner HN, Gjedde A (1988) In vivo measurement of dopamine receptors in human brain by positron emission tomography: age and sex differences. Ann N Y Acad Sci 515:203-214